DHG Pharmaceutical Joint Stock Company reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was VND 1,099,461.73 million compared to VND 1,161,685.13 million a year ago. Net income was VND 166,075.55 million compared to VND 262,386.79 million a year ago. Basic earnings per share from continuing operations was VND 1,228 compared to VND 1,943 a year ago.
For the nine months, revenue was VND 3,480,669.68 million compared to VND 3,345,727.53 million a year ago. Net income was VND 790,374.43 million compared to VND 752,257.1 million a year ago. Basic earnings per share from continuing operations was VND 5,852 compared to VND 5,569 a year ago.